Notably, in all forms of human carcinoma examined to date, high tumour expression of fascin protein is of clinical significance and is associated with a poor prognosis in carcinomas of the lung, oesophagus, stomach, colon, breast and kidney [5], [11], [12], [14]–[17]. This evidence concerns the gene FSCN1 and carcinoma.